Clinical Trials in Alessandria, Piedmont
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
Pirfenidone to Prevent Fibrosis in Ards.
Acute Respiratory Distress Syndrome (ARDS)
Università Vita-Salute San Raffaele130 enrolled17 locationsNCT05075161
Recruiting
Phase 3
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Lymphoma
Hoffmann-La Roche182 enrolled76 locationsNCT06084936
Recruiting
Phase 3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerHER2-Negative Breast Carcinoma+2 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738
Recruiting
Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Relapsed Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals410 enrolled159 locationsNCT05730036
Recruiting
Phase 4
Landiolol in Mitral Valve Surgery
Cardiac FailureLow Cardiac Output Syndrome
Università Vita-Salute San Raffaele1,500 enrolled13 locationsNCT06793670
Recruiting
Comparison of the Resection Site Order in Simultaneous Approach of Colorectal Liver Metastasis
Colorectal Liver Metastasis
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria500 enrolled1 locationNCT07272928
Recruiting
PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa
Pancreatic Ductal Adenocarcinoma
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria120 enrolled1 locationNCT07252076
Recruiting
Not Applicable
Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment
Mild Cognitive Impairment (MCI)
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria120 enrolled1 locationNCT06951932